Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 51 (TMEM51) is a membrane protein encoded by the TMEM51 gene (also known as C1orf72) located on human chromosome 1. TMEM51 is predicted to reside in cellular membranes and is primarily implicated in general cell signaling rather than specific receptor-mediated pathways. It has been associated through genetic studies with several diseases, principally neurological (migraine, epilepsy) and retinal disorders, as well as diabetes and autoimmune diseases. While its detailed molecular function is not fully elucidated, some evidence suggests a role in modulating diacylglycerol signaling and oxidative stress responses, especially when observed in the context of gene fusions. TMEM51 itself is not currently an established therapeutic target, nor is it targeted by any known drugs. However, long non-coding RNAs transcribed from the TMEM51 locus (such as TMEM51-AS1) are being studied as potential cancer biomarkers or therapeutic oligonucleotide targets, although these findings pertain to the non-coding RNA rather than the protein itself.
Not applicable (no drugs directly targeting TMEM51 identified).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 51 (TMEM51).